Value of oxidant lipid lowering effect by statin intervention in hypercholesterolemia (VISION Study).
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2013
At a glance
- Drugs Atorvastatin (Primary) ; Pitavastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Biomarker; Therapeutic Use
- Acronyms VISION
- 22 Mar 2013 Status changed from recruiting to completed, based on results in Atherosclerosis.
- 25 Mar 2009 New trial record.